Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design

Ítems similars

• Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial
  per: Bhattacharya, Indrani S., et al.
  Publicat: (2019)
• Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial
  per: Bhattacharya, Indrani S., et al.
  Publicat: (2019)
• Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial
  per: Bhattacharya, Indrani S., et al.
  Publicat: (2019)
• Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
  per: Murray Brunt, Adrian, et al.
  Publicat: (2020)
• Primetime for γ′
  per: Farrell, David H.
  Publicat: (2014)